首页> 外文期刊>European journal of human genetics: EJHG >Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland.
【24h】

Tracing past population migrations: genealogy of steroid 21-hydroxylase (CYP21) gene mutations in Finland.

机译:追踪过去的人口迁移:芬兰的类固醇21-羟化酶(CYP21)基因突变的族谱。

获取原文
获取原文并翻译 | 示例
           

摘要

The genealogic origin of steroid 21-hydroxylase gene (CYP21) mutations and associated haplotypes was determined in 74 unrelated Finnish families with CYP21 deficiency (congenital adrenal hyperplasia, CAH). These families account for two thirds (85/119) of all diagnosed patients of Finnish descent found in this country. We recently demonstrated that multiple founder mutations each associated with a particular haplotype can be found in Finland. Interestingly, some of the haplotypes were identical to those observed in various European populations, whereas others have not been described elsewhere, indicating a local and perhaps a more recent origin. In the present report we show that each of the major founder haplotypes originates from a particular geographic region of Finland. Thus many local genetic isolates are to be expected in Finland. Our finding is in a clear contrast to the genetic diseases known as the 'Finnish disease heritage', in which only one mutation usually predominates. Some of the CYP21 haplotypes proved very informative for analysis of the history of the Finnish population. For example, the origin of one frequent haplotype was shown to cluster in a region assumed by archaeological data to be a major site of immigration by settlers of either Scandinavian or Baltic origin during the first centuries AD. As this haplotype is frequent in many European patient populations, we provide independent genetic evidence of this Iron Age immigration. On the other hand, another frequent haplotype found solely in Finland reflects a more recent (post 15th century) settlement expansion. Consequently, well characterised and sufficiently frequent autosomal gene markers can provide useful information on migrations both between and within populations.
机译:在74个不相关的CYP21缺乏症(先天性肾上腺皮质增生,CAH)的芬兰无关家庭中,确定了类固醇21-羟化酶基因(CYP21)突变和相关单倍型的谱系起源。这些家庭占该国所有芬兰血统确诊患者的三分之二(85/119)。我们最近证明,在芬兰可以找到多个与特定单倍型相关的创始人突变。有趣的是,某些单倍型与在欧洲不同人群中观察到的单倍型相同,而其他一些单倍型没有在其他地方进行描述,这表明它们是本地的,也可能是较新的起源。在本报告中,我们显示了每个主要的创始人单倍型都来自芬兰的特定地理区域。因此,预计芬兰将有许多本地遗传分离株。我们的发现与被称为“芬兰疾病遗产”的遗传疾病形成鲜明对比,在遗传疾病中通常只有一种突变占主导地位。某些CYP21单倍型被证明对分析芬兰人口的历史很有帮助。例如,在公元前几个世纪中,一个频繁的单倍型的起源被证明聚集在一个被考古数据认为是斯堪的纳维亚或波罗的海定居者移民的主要地点的地区。由于这种单倍型在许多欧洲患者人群中都很常见,因此我们提供了铁器时代移民的独立遗传证据。另一方面,仅在芬兰发现的另一种常见单倍型反映了最近(15世纪后)定居点的扩张。因此,特征明确且足够频繁的常染色体基因标记可以提供有关种群之间和种群内迁移的有用信息。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号